{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:38:05Z","timestamp":1786991885829,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012236","name":"Beijing Institute of Technology Research Fund Program for Young Scholars","doi-asserted-by":"publisher","award":["XSQD-202213001"],"award-info":[{"award-number":["XSQD-202213001"]}],"id":[{"id":"10.13039\/501100012236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005085","name":"Beijing Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2024QC203"],"award-info":[{"award-number":["ZR2024QC203"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114464","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T07:42:10Z","timestamp":1764056530000},"page":"114464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Lymph node delivery of immunogenic dendritic cell exosomes via extended-tip microneedles for cancer prevention"],"prefix":"10.1016","volume":"389","author":[{"given":"Shijie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114464_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114464_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2025.114464_bb0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/1940-6207.CAPR-15-0406","article-title":"Transforming Cancer prevention through precision medicine and immune-oncology","volume":"9","author":"Kensler","year":"2016","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.jconrel.2025.114464_bb0020","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1158\/1078-0432.CCR-16-0695","article-title":"Cancer prevention and interception: a new era for Chemopreventive approaches","volume":"22","author":"Albini","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114464_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102429","article-title":"Therapeutic cancer vaccines: from biological mechanisms and engineering to ongoing clinical trials","volume":"109","author":"Sobhani","year":"2022","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2025.114464_bb0030","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13045-022-01247-x","article-title":"Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0035","first-page":"809","article-title":"Next-generation immunotherapies for brain metastatic cancers, trends","volume":"7","author":"L\u00f3pez V\u00e1zquez","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri.2017.140","article-title":"The dawn of vaccines for cancer prevention","volume":"18","author":"Finn","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0045","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1158\/1078-0432.CCR-14-1186","article-title":"Nonviral oncogenic antigens and the inflammatory signals driving early Cancer development as targets for Cancer Immunoprevention","volume":"21","author":"Chu","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2025.114464_bb0050","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1608077113","article-title":"Leveraging premalignant biology for immune-based cancer prevention","volume":"113","author":"Spira","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2025.114464_bb0055","doi-asserted-by":"crossref","first-page":"2300016","DOI":"10.1002\/sstr.202300016","article-title":"Emerging Nano-immunotherapeutic approaches to glioma","volume":"4","author":"Nan","year":"2023","journal-title":"Small Struct."},{"key":"10.1016\/j.jconrel.2025.114464_bb0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tips.2019.12.003","article-title":"Immunotherapy for malignant glioma: current status and future directions","volume":"41","author":"Wang","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2025.114464_bb0070","first-page":"509","article-title":"Therapeutic vaccines for cancer: an overview of clinical trials, nature reviews","volume":"11","author":"Melero","year":"2014","journal-title":"Clin. Oncol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"npj Vaccines"},{"key":"10.1016\/j.jconrel.2025.114464_bb0080","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41392-023-01674-3","article-title":"Therapeutic cancer vaccines: advancements, challenges and prospects","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2025.114464_bb0085","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/s41590-024-01899-6","article-title":"Direct presentation of inflammation-associated self-antigens by thymic innate-like T cells induces elimination of autoreactive CD8+ thymocytes","volume":"25","author":"You","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0090","first-page":"937","article-title":"The landscape of T cell antigens for cancer immunotherapy, nature","volume":"4","author":"Peri","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0095","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0105","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41568-025-00820-z","article-title":"Recent advances in therapeutic cancer vaccines","volume":"25","author":"Zaidi","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0110","series-title":"Survivin Small Molecules Inhibitors: Recent Advances and Challenges","author":"Albadari","year":"2023"},{"key":"10.1016\/j.jconrel.2025.114464_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s12015-020-09995-4","article-title":"Emerging importance of Survivin in stem cells and Cancer: the development of new Cancer therapeutics","volume":"16","author":"Warrier","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.jconrel.2025.114464_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122260","article-title":"Targeting survivin for cancer therapy: strategies, small molecule inhibitors and vaccine based therapeutics in development","volume":"335","author":"Kondapuram","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2025.114464_bb0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/blood-2002-08-2554","article-title":"Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells","volume":"102","author":"Schmidt","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2025.114464_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122788","article-title":"Survivin (BIRC5): implications in cancer therapy","volume":"350","author":"Siragusa","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2025.114464_bb0135","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12885-022-09371-0","article-title":"Pan-cancer analysis identifies BIRC5 as a prognostic biomarker","volume":"22","author":"F\u00e4ldt Beding","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2025.114464_bb0140","doi-asserted-by":"crossref","first-page":"8727925","DOI":"10.1155\/2019\/8727925","article-title":"Potential involvement of BIRC5 in maintaining pluripotency and cell differentiation of human stem cells","volume":"2019","author":"Gil-Kulik","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.jconrel.2025.114464_bb0145","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1038\/sj.leu.2403510","article-title":"Identification of a survivin-derived peptide that induces HLA-A*0201-restricted antileukemia cytotoxic T lymphocytes","volume":"18","author":"Siegel","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2025.114464_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jconrel.2025.114464_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-020-00939-6","article-title":"Dendritic cell biology and its role in tumor immunotherapy","volume":"13","author":"Wang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0160","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jconrel.2015.09.063","article-title":"Engineering immunity: modulating dendritic cell subsets and lymph node response to direct immune-polarization and vaccine efficacy","volume":"219","author":"Leleux","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114464_bb0165","doi-asserted-by":"crossref","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2025.114464_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113250","article-title":"Recent progress of dendritic cell-derived exosomes (Dex) as an anti-cancer nanovaccine","volume":"152","author":"Xia","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2025.114464_bb0175","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1172\/JCI81137","article-title":"Dendritic cell\u2013derived exosomes for cancer therapy","volume":"126","author":"Pitt","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2025.114464_bb0180","doi-asserted-by":"crossref","first-page":"2005709","DOI":"10.1002\/adma.202005709","article-title":"Engineered extracellular vesicles for Cancer therapy","volume":"33","author":"Zhang","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2025.114464_bb0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jconrel.2022.11.053","article-title":"Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies","volume":"353","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114464_bb0190","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.jconrel.2025.114464_bb0195","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8\u03b1+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2025.114464_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.it.2012.10.004","article-title":"Type I interferon response and innate immune sensing of cancer","volume":"34","author":"Fuertes","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2025.114464_bb0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925010788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:47:13Z","timestamp":1781326033000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925010788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0168365925010788"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114464","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymph node delivery of immunogenic dendritic cell exosomes via extended-tip microneedles for cancer prevention","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114464","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114464"}}